Freyr added a new strategic client for it’s specialized regulatory submissions services with an UAE based Specialty Pharma Company that provides one-stop-solution to pharmaceuticals, biological, genomics and other innovative healthcare companies.
As part of the project scope, Freyr will commence and provide end-to-end support for submission of a New Drug Application (NDA) to the Saudi Food and Drug Authority (SFDA) including variations. Freyr will leverage its deep capabilities and skills to drive improvements in the planning and delivery of critical submission project, as well as generate process efficiencies.
“Today’s businesses demand the highest level of service availability and stability, and Freyr is well-positioned to support these critical requirements”, commented Sudheer Sagar, VP Operations, Freyr. “Freyr offers a comprehensive suite of regulatory submission services that impart intelligence into service delivery, reducing operations costs, improving performance and accelerating speed to market.”